The time line for results has blown out a little...doesn't really bother me, the original timeline was always ambitious.
This from November presentation:
And from today:
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren submits IND & first patients complete Phase 2 trials
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.91%
!
$13.10

Ann: Neuren submits IND & first patients complete Phase 2 trials, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.10 |
Change
0.245(1.91%) |
Mkt cap ! $1.628B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.92 | $5.097M | 388.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 600 | $13.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.10 | 467 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 70 | 13.070 |
6 | 367 | 13.060 |
12 | 4315 | 13.050 |
7 | 1399 | 13.040 |
9 | 1393 | 13.030 |
Price($) | Vol. | No. |
---|---|---|
13.080 | 915 | 8 |
13.090 | 1324 | 16 |
13.100 | 2041 | 15 |
13.110 | 1457 | 8 |
13.120 | 1391 | 4 |
Last trade - 13.47pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online